Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06777784 · ClinicalTrials.gov registry record · NA

Modern Nicotine Oral Product Abuse Liability

A NA study of Smoking and Tobacco Use, sponsored by RAI Services Company.

Completed
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT06777784 is a NA study of Smoking and Tobacco Use that has completed, run by RAI Services Company. The registered enrollment target is 40 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06777784, a NA study of Smoking and Tobacco Use, has completed, sponsored by RAI Services Company.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

This is a two-site, open-label, randomized, 8-way cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]) and plasma nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use of the study investigational products (IPs) by generally healthy smokers.

Conditions Studied

Interventions

  • OTHER Product A
  • OTHER Product B
  • OTHER Product C
  • OTHER Product D
  • OTHER Product E

Study Locations (2)

Kentucky

  • AMR Lexington - Lexington

Tennessee

  • AMR Knoxville - Knoxville

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-02-03
Est. Completion 2025-03-05
Phase NA

Sponsor

RAI Services Company

42 total trials

What the Registry Record Tells You About NCT06777784

The ClinicalTrials.gov registry entry for NCT06777784 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (91% lower). The listed sponsor is RAI Services Company, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 5 interventions - of which Product A is the first listed.

NCT06777784 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, Tennessee.

Frequently Asked Questions

What is clinical trial NCT06777784 about?

NCT06777784 is a clinical study titled "Modern Nicotine Oral Product Abuse Liability". This is a two-site, open-label, randomized, 8-way cross-over study designed to evaluate elements of abuse liability (AL) including subjective effects and physiological measures (pharmacodynamics \[PD\]) and plasma nicotine uptake (pharmacokinetics \[PK\]) during and following ad libitum use of the s...

What is the current status of trial NCT06777784?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2025-02-03. Estimated completion is 2025-03-05.

What conditions does trial NCT06777784 study?

This clinical trial studies the following conditions: Smoking, Tobacco Use.

What interventions are being tested in trial NCT06777784?

The interventions under investigation include: Product A (OTHER), Product B (OTHER), Product C (OTHER), Product D (OTHER), Product E (OTHER).

Who is sponsoring clinical trial NCT06777784?

This trial is sponsored by RAI Services Company, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06777784 being conducted?

This trial has 2 study locations across Kentucky, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Smoking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.